Opus Genetics, Inc. (IRD) P/S ratio

P/S ratio today
17.8×

Opus Genetics, Inc. (IRD) trades at 17.8× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 8.8×. That is 204.6% higher than the 2.9× of fiscal 2024. Figures as of 18 Nov 2026, 10:29 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
17.8×
P/S ratio, fiscal 2025
8.8×
Change on fiscal 2024
+204.6%
Highest on record
94.1×fiscal 2021
Lowest on record
1.8×fiscal 2022
Fiscal years on record
52021–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Opus Genetics, Inc. P/S ratio, in more detail

Today's figure is 101.5% above the fiscal 2025 year-end.

Across the 5 fiscal year-ends on record (2021–2025), the highest was 94.1× in fiscal 2021 and the lowest 1.8× in fiscal 2022. Today's P/S ratio is higher than at 80% of the 5 fiscal year-ends on record; their median is 3.4×.

History · 5 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Opus Genetics, Inc. P/S ratio, year by year

Opus Genetics, Inc. (IRD) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today17.8×—$4.05—
20258.8× 204.6% up$2.01$0.23
20242.9× 15.2% down$1.19$0.41
20233.4× 87.0% up$3.01$0.88
20221.8× 98.1% down$3.53$1.93
202194.1×—$3.73$0.04
2020——$6.49—
2019——$7.64—
2018——$44.64—
2017——$96.96—
2016——$67.20—
2015——$172.80—
2014——$336.00—
2013——$244.80—
2012——$148.80—
2011——$182.40—
2010——$537.60—
2009——$326.40—
2008——$427.20—
2007——$1,080.00—
2006——$648.00—
2005——$960.00—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

More on IRD

Opus Genetics, Inc., figure by figure

Opus Genetics, Inc. (IRD) overview: price, valuation and scorecard

Opus Genetics, Inc. P/S ratio: questions and answers

What is Opus Genetics, Inc.'s P/S ratio?

Opus Genetics, Inc. (IRD) trades at 17.8× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 8.8×. That is 204.6% higher than the 2.9× of fiscal 2024.

Is Opus Genetics, Inc.'s P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 80% of the 5 fiscal year-ends on record; their median is 3.4×.

What are the highest and lowest P/S ratio figures on record for Opus Genetics, Inc.?

Across the 5 fiscal year-ends on record (2021–2025), the highest was 94.1× in fiscal 2021 and the lowest 1.8× in fiscal 2022.

How is Opus Genetics, Inc.'s P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Opus Genetics, Inc. it is on record here for 5 fiscal years, 2021 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Opus Genetics, Inc. (IRD) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/IRD/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.